-
By Rory Horner The Indian embassy in Iran recently celebrated the arrival of 1 million doses of Covaxin, a Covid vaccine developed in India by the pharmaceutical company Bharat Biotech. Bangladesh, Myanmar and Iran also recently received a million doses each of Covishield, the version of the Oxford/AstraZeneca vaccine produced by the Serum Institute of […]
-
As the euphoria over reaching the one billion dose milestone subsides, there is a growing realisation that a lot of work remains to be done and there is no need for premature celebration. India needs to significantly ramp up vaccine production to meet its target of inoculating the entire adult population — nearly 95 crore […]
-
The Covishield vaccine, which has been developed by British-Swedish pharmaceutical company AstraZeneca, is manufactured in India by Pune-based Serum Institute of India.
-
New Delhi: The Co-founder and Joint Managing Director of Hyderabad-based Bharat Biotech, Suchitra Ella has said that vaccines should not be a barrier to enter into any nation. Amid the ongoing row over new UK travel restrictions that consider fully Indian vaccinated as unvaccinated and prescribes 10-day quarantine, she said, “Vaccines must not be entry […]
-
Kochi: The Kerala High Court has directed the Centre to allow scheduling, on CoWIN portal, of second COVISHIELD dose after four weeks from the first for those who want to take it earlier than the present suggested gap of 84 days. Justice P B Suresh Kumar said that if the central and state governments can […]
-
Sustaining the momentum of the focused push to vaccination needs to remain a high priority
-
Planning at the district level in India will be crucial in the journey ahead
-
It is argued that such a mixed regimen will help overcome the challenges of the shortfall of certain vaccines and remove hesitancy, especially in settings where multiple Covid-19 vaccines are being used
-
An expert panel of the Central Drugs Standard Control Organisation (CDSCO) on July 29 had recommended granting permission for conducting the study.
-
The results of a study conducted by ICMR showed that the people in the mix and match group had superior immunogenicity profiles against Alpha, Beta and Delta variants of Covid-19
-
More than half of the adult population has yet to receive even a single dose, despite a slight improvement in coverage in July
-
The WHO listed "vaccine hesitancy" as among the top 10 threats to global health.
-
The rate of mortality was found to be about 50% lower in fully vaccinated individuals having a breakthrough infection, according to CCMB, AIg study
-
The analysis of breakthrough cases is a clear indication that vaccines are the best bet to reduce severity and fatalities among Covid-19 patients.
-
Hyderabad: After the Delta and Delta Plus variants of the Covid-19, a new strain – Kappa – has been discovered and three people infected with this strain of SARS-Cov-2 were recently reported in Uttar Pradesh. With one of the three patients infected with the Kappa variant succumbing to it, there is a now a sense […]
-
According to senior doctors in Hyderabad, at some point in the near future, as the protection provided by Covid vaccines wane, there will be demand for booster shots
-
Drug regulatory authorities keen on fast-tracking approvals of new Covid vaccine candidates
-
India has already asked the EU member countries to individually consider allowing Indians who have taken Covishield and Covaxin vaccines and want to travel to Europe.
-
Moderna's vaccine will be the fourth COVID-19 jab to be available in India after Covishield, Covaxin and Sputnik
-
All eligible persons can now walk into designated Govt Covid Vaccination Centres in nine districts and have to produce a valid passport and a work permit visa